Polland Allison, Vertosick Emily A, Sjoberg Daniel D, Stearns Gillian L, Leddy Laura S, Kollmeier Marisa A, Sandhu Jaspreet S
MedStar Washington Hospital Center, Washington, District of Columbia, USA.
Can J Urol. 2017 Aug;24(4):8903-8909.
Lower urinary tract symptoms and retention are known complications of radiation for prostate cancer and traditionally transurethral resection of the prostate (TURP) has been avoided in these patients because of the risk of incontinence. The purpose of this study was to evaluate the incidence and predictors of post-TURP incontinence in previously radiated patients.
One-hundred and eleven patients who underwent brachytherapy or external beam radiotherapy for prostate cancer with subsequent TURP performed between 1992 and 2012 at a single institution were identified. We tested for associations between post-TURP continence status and pre-TURP predictors including age, preoperative urinary symptoms and type and timing of radiation therapy.
New-onset incontinence developed in 27% (95% CI 17%, 39%) of patients after first post-radiation TURP and 32% (95% CI 23%, 42%) of patients after any TURP, including repeat TURPs. Forty-three percent of patients had resolution of incontinence with first TURP (95% CI 25%, 63%); only 25% (95% CI 7%, 52%) of patients had resolution following repeat TURPs. Age was significantly associated with incontinence (OR per 10 years 2.02, 95% CI 1.10, 3.74, p = 0.024). Post-TURP incontinence was more common in men with pre-TURP urgency.
Rates of post-TURP incontinence were higher in men who were older or had pre-TURP urinary urgency. Assessment of preoperative symptoms would allow for better patient selection. Further research should determine whether this results in better outcomes, including decreased incidence of new onset incontinence and increase in resolution of incontinence.
下尿路症状和尿潴留是前列腺癌放疗已知的并发症,传统上,由于存在尿失禁风险,这些患者一直避免行经尿道前列腺切除术(TURP)。本研究的目的是评估既往接受过放疗的患者TURP术后尿失禁的发生率及预测因素。
确定了1992年至2012年在单一机构接受前列腺癌近距离放疗或外照射放疗并随后接受TURP的111例患者。我们测试了TURP术后控尿状态与TURP术前预测因素之间的关联,这些因素包括年龄、术前尿路症状以及放疗类型和时间。
首次放疗后TURP术后,27%(95%可信区间17%,39%)的患者出现新发尿失禁;在包括重复TURP在内的任何TURP术后,32%(95%可信区间23%,42%)的患者出现尿失禁。43%的患者在首次TURP术后尿失禁症状得到缓解(95%可信区间25%,63%);重复TURP术后只有25%(95%可信区间7%,52%)的患者症状得到缓解。年龄与尿失禁显著相关(每10岁的比值比为2.02,95%可信区间1.10,3.74,p = 0.024)。TURP术前有尿急症状的男性,TURP术后尿失禁更为常见。
年龄较大或TURP术前有尿路尿急症状的男性,TURP术后尿失禁发生率较高。术前症状评估有助于更好地选择患者。进一步的研究应确定这是否会带来更好的结果,包括降低新发尿失禁的发生率和提高尿失禁症状缓解率。